Edgewise Therapeutics Inc. (EWTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Edgewise Therapeutics Inc...

    NASDAQ: EWTX · Real-Time Price · USD
    15.65
    0.65 (4.33%)
    At close: Oct 03, 2025, 3:59 PM
    15.90
    1.60%
    After-hours: Oct 03, 2025, 04:28 PM EDT

    Edgewise Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -18.44 -6.96 -7.08 -17.67
    PEG Ratio
    		 2.41 -0.28 -0.15 -0.12
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 5.37 2.19 1.38 2.76
    P/FCF Ratio
    		 -22.36 -7.14 -8.24 -22.13
    P/OCF Ratio
    		 -22.63 -7.58 -9.1 -22.57
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.01 0.02 0.01 n/a
    Quick Ratio
    		 19.93 19.50 21.53 26.97
    Current Ratio
    		 19.93 19.50 21.53 26.97
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -5.5 n/a
    Return on Equity
    		 -0.29 -0.31 -0.2 -0.16
    Return on Assets
    		 -0.27 -0.29 -0.18 -0.15
    Return on Invested Capital
    		 -0.34 -0.35 -0.06 -0.16
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist